AKT1 and neoplasm: PD-L1 expression not only mediates immune evasion but also directly modulates tumor aggressiveness, as demonstrated by AKT-mTOR inhibitor studies showing reduced migration, invasion, and growth rates of DU-145 and PC-3 cells in murine models (91).